Search Results - "BETHKE, K. P"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques by Morrow, Monica, Rademaker, Alfred W., Bethke, Kevin P., Talamonti, Mark S., Dawes, Lillian G., Clauson, Jennifer, Hansen, Nora

    Published in Surgery (01-10-1999)
    “…Background: Evidence indicates that sentinel node (SN) biopsy can accurately predict axillary nodal status. Debate exists as to the optimal method of SN…”
    Get full text
    Journal Article
  3. 3

    Diagnosis and management of sacrococcygeal chordoma by Bethke, K P, Neifeld, J P, Lawrence, Jr, W

    Published in Journal of surgical oncology (01-12-1991)
    “…Chordoma is a rare, slow-growing but locally aggressive malignant tumor derived from the primitive notochord and located along the axial skeleton. Between 1973…”
    Get more information
    Journal Article
  4. 4

    Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx by Frank, J L, Garb, J L, Kay, S, McClish, D K, Bethke, K P, Lind, D S, Mellis, M, Slomka, W, Sismanis, A, Neifeld, J P

    Published in The American journal of surgery (01-11-1994)
    “…Postoperative radiation is considered to be "standard of care" therapy for advanced, resectable squamous cell carcinoma of the head and neck. This approach has…”
    Get more information
    Journal Article
  5. 5

    Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients by Lind, D S, Tuttle, T M, Bethke, K P, Frank, J L, McCrady, C W, Bear, H D

    Published in Surgical oncology (01-10-1993)
    “…Current adoptive immunotherapy strategies in cancer patients require large numbers of activated T-cells and are limited by the availability of autologous…”
    Get more information
    Journal Article
  6. 6

    Bryostatin 1-activated T cells can traffic and mediate tumor regression by Tuttle, T M, Bethke, K P, Inge, T H, McCrady, C W, Pettit, G R, Bear, H D

    Published in The Journal of surgical research (01-06-1992)
    “…Adoptive immunotherapy in humans may be limited by the lack of autologous tumor cells to activate and expand tumor-specific T cells. Pharmacologic manipulation…”
    Get more information
    Journal Article
  7. 7

    Successful long-term cryopreservation and transplantation of human fetal pancreas by Hullett, D. A., Bethke, K. P., Landry, A. S., Leonard, D. K., Sollinger, H. W.

    Published in Diabetes (New York, N.Y.) (01-04-1989)
    “…Successful long-term cryopreservation and transplantation of human fetal pancreas. D A Hullett , K P Bethke , A S Landry , D K Leonard and H W Sollinger…”
    Get full text
    Journal Article
  8. 8

    Relationship of recent pregnancy and cytologic atypia in the contralateral breast of patients with breast cancer by Revesz, E., Zalles, C. M., Ivancic, D., Bethke, K. P., Hansen, N. M., Jeruss, J. S., Khan, S. A.

    Published in Journal of clinical oncology (20-09-2011)
    “…Abstract only 149 Background: Although early parity protects against breast cancer later in life, it is a risk factor in the years following pregnancy,…”
    Get full text
    Journal Article
  9. 9

    Breast cancer characteristics in yielders and nonyielders of nipple aspiration fluid by Brutus, V., McGathey, C., Kmiecik, T., Bethke, K. P., Jeruss, J. S., Hansen, N. M., Khan, S. A.

    Published in Journal of clinical oncology (20-09-2011)
    “…Abstract only 71 Background: Nipple aspirate fluid (NAF) is an attractive biosample for the investigation of breast cancer risk factors. The reported NAF yield…”
    Get full text
    Journal Article
  10. 10

    Prognostic classification of ipsilateral breast tumor recurrence (IBTR) by Eladoumikdachi, F. G., Jones, M., Shidfar, A., Helenowski, I. B., Franz, J. M., Scholtens, D., Sullivan, M. E., Bethke, K. P., Hansen, N. M., Jeruss, J. S., Khan, S. A.

    Published in Journal of clinical oncology (20-09-2011)
    “…Abstract only 137 Background: IBTR after breast conservation encompasses true recurrence (TR) and new primary cancer (NP). No clear criteria distinguish TR…”
    Get full text
    Journal Article
  11. 11

    Successful long-term cryopreservation and transplantation of human fetal pancreas by Hullett, D A, Bethke, K P, Landry, A S, Leonard, D K, Sollinger, H W

    Published in Diabetes (New York, N.Y.) (01-04-1989)
    “…To obtain sufficient quantities of human fetal pancreatic tissue (HFP) for transplantation, long-term storage of the tissue must be achieved. The functional…”
    Get full text
    Journal Article
  12. 12

    Breast conservation: Predictors and treatment of local recurrence by Bethke, Kevin P.

    Published in Seminars in surgical oncology (01-09-1996)
    “…Breast conservation therapy has become the preferred treatment for many Stage I and II breast cancers as the “Halstedian” theory of sequential spread has been…”
    Get full text
    Journal Article
  13. 13

    Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide by INGE, T. H, HOOVER, S. K, FRANK, J. L, KAWABATA, T. T, BETHKE, K. P, BEAR, H. D

    Published in Cancer Immunology Immunotherapy (01-03-1992)
    “…Mafosfamide (Mafo) is an analog of cyclophosphamide that does not require hepatic activation and therefore has in vitro activity. The present study was…”
    Get full text
    Journal Article
  14. 14

    Activation and growth of murine tumor-specific T-cells which have In vivo activity with bryostatin 1 by TUTTLE, T. M, INGE, T. H, BETHKE, K. P, MCCRADY, C. W, PETTIT, G. R, BEAR, H. D

    Published in Cancer research (Chicago, Ill.) (01-02-1992)
    “…We examined the ability of bryostatin 1 (Bryo), a novel protein kinase C activator, plus ionomycin (Io), a calcium ionophore, to activate T-cells with specific…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophore by Tuttle, T M, Inge, T H, McCrady, C M, Bethke, K P, Bear, H D

    Published in Journal of immunotherapy (01-07-1992)
    “…When lymphocytes from the lymph nodes draining the site of a progressively growing MCA-105 sarcoma are stimulated in vitro with autologous tumor and low-dose…”
    Get more information
    Journal Article
  17. 17

    Abstract P3-14-14: Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients by Giordano, SB, Jeruss, JS, Bethke, KP, Hansen, NM, Khan, S, Von Roenn, J, Rosen, S, Gradishar, WL, Siziopikou, KP, Meservey, C, Kaklamani, V

    Published in Cancer research (Chicago, Ill.) (15-12-2013)
    “…Background: Several neoadjuvant trials have been conducted directed at treating triple negative breast cancer (TNBC) patients with platinum agents with…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20